{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:50:45Z","timestamp":1786985445389,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50 AI-30639"],"award-info":[{"award-number":["P50 AI-30639"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.bone.2017.03.053","type":"journal-article","created":{"date-parts":[[2017,4,5]],"date-time":"2017-04-05T22:30:21Z","timestamp":1491431421000},"page":"21-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Normal bone density and trabecular bone score, but high serum sclerostin in congenital generalized lipodystrophy"],"prefix":"10.1016","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1627-7018","authenticated-orcid":false,"given":"Josivan Gomes","family":"Lima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia Helena C.","family":"Nobrega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia Nobrega","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel Cat\u00e3o Ferreira","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria de Fatima P.","family":"Baracho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renaud","family":"Winzenrieth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Bandeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina de O.","family":"Mendes-Aguiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Paulo Freire","family":"Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo Capistrano","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford J.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma Maria B.","family":"Jeronimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bone.2017.03.053_bb0005","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1210\/jcem-14-2-193","article-title":"An undiagnosed endocrinometabolic syndrome: report of 2 cases","volume":"14","author":"Berardinelli","year":"1954","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2017.03.053_bb0010","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1651-2227.1959.tb17558.x","article-title":"Lipodystrophy and gigantism with associated endocrine manifestations. A new diencephalic syndrome?","volume":"48","author":"Seip","year":"1959","journal-title":"Acta Paediatr."},{"issue":"9","key":"10.1016\/j.bone.2017.03.053_bb0015","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1210\/jcem.84.9.6103","article-title":"A gene for congenital generalized lipodystrophy maps to human chromosome 9q34","volume":"84","author":"Garg","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.bone.2017.03.053_bb0020","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ng585","article-title":"Identification of the gene altered in Berardinelli\u2013Seip congenital lipodystrophy on chromosome 11q13","volume":"28","author":"Magre","year":"2001","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.bone.2017.03.053_bb0025","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1210\/jc.2007-1328","article-title":"Association of a homozygous nonsense caveolin-1 mutation with Berardinelli\u2013Seip congenital lipodystrophy","volume":"93","author":"Kim","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.bone.2017.03.053_bb0030","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1172\/JCI38660","article-title":"Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy","volume":"119","author":"Hayashi","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.bone.2017.03.053_bb0035","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrendo.2015.123","article-title":"Congenital generalized lipodystrophies\u2014new insights into metabolic dysfunction","volume":"11","author":"Patni","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bone.2017.03.053_bb0040","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13098-016-0140-x","article-title":"Clinical and laboratory data of a large series of patients with congenital generalized lipodystrophy","volume":"8","author":"Lima","year":"2016","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.bone.2017.03.053_bb0045","article-title":"Bone density in patients with Berardinelli\u2013Seip congenital lipodystrophy is higher in trabecular sites and in type 2 patients","author":"Lima","year":"2016","journal-title":"J. Clin. Densitom."},{"key":"10.1016\/j.bone.2017.03.053_bb0050","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.mehy.2016.10.025","article-title":"Conversations between insulin and bone: potential mechanism of high bone density in patients with Berardinelli\u2013Seip congenital lipodystrophy","volume":"97","author":"Lima","year":"2016","journal-title":"Med. Hypotheses"},{"issue":"6","key":"10.1016\/j.bone.2017.03.053_bb0055","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/jcb.25432","article-title":"Sclerostin enhances adipocyte differentiation in 3T3-L1 cells","volume":"117","author":"Ukita","year":"2016","journal-title":"J. Cell. Biochem."},{"issue":"5","key":"10.1016\/j.bone.2017.03.053_bb0060","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1210\/jc.2011-2958","article-title":"Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes","volume":"97","author":"Gennari","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.bone.2017.03.053_bb0065","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.bone.2017.03.053_bb0070","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1590\/S0004-27302009000200020","article-title":"HOMA1-IR and HOMA2-IR indexes in identifying insulin resistance and metabolic syndrome: Brazilian Metabolic Syndrome Study (BRAMS)","volume":"53","author":"Geloneze","year":"2009","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"issue":"7","key":"10.1016\/j.bone.2017.03.053_bb0075","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Holick","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bone.2017.03.053_bb0080","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jocd.2007.12.004","article-title":"Dual-energy X-ray aborptiometry assessment in children and adolescents with diseases that may affect the skeleton: the 2007 ISCD Pediatric Official Positions","volume":"11","author":"Bishop","year":"2008","journal-title":"J. Clin. Densitom."},{"issue":"1","key":"10.1016\/j.bone.2017.03.053_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/JCD:8:1:001","article-title":"Misinterpretation of osteodensitometry with high bone density: BMD Z > or = +2.5 is not \u201cnormal\u201d","volume":"8","author":"Whyte","year":"2005","journal-title":"J. Clin. Densitom."},{"issue":"3","key":"10.1016\/j.bone.2017.03.053_bb0090","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jocd.2011.05.005","article-title":"Correlations between trabecular bone score, measured using anteroposterior dual-energy X-ray absorptiometry acquisition, and 3-dimensional parameters of bone microarchitecture: an experimental study on human cadaver vertebrae","volume":"14","author":"Hans","year":"2011","journal-title":"J. Clin. Densitom."},{"issue":"4","key":"10.1016\/j.bone.2017.03.053_bb0095","doi-asserted-by":"crossref","first-page":"323","DOI":"10.14310\/horm.2002.1552","article-title":"The sclerostin story: from human genetics to the development of novel anabolic treatment for osteoporosis","volume":"13","author":"Yavropoulou","year":"2014","journal-title":"Hormones (Athens)"},{"issue":"2","key":"10.1016\/j.bone.2017.03.053_bb0100","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/jbmr.2351","article-title":"A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density","volume":"30","author":"Recker","year":"2015","journal-title":"J. Bone Miner. Res."},{"issue":"8","key":"10.1016\/j.bone.2017.03.053_bb0105","doi-asserted-by":"crossref","first-page":"E1493","DOI":"10.1210\/jc.2014-1353","article-title":"Bone mineral content in patients with congenital generalized lipodystrophy is unaffected by metreleptin replacement therapy","volume":"99","author":"Christensen","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.bone.2017.03.053_bb0110","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2337\/dc14-2989","article-title":"Sclerostin and insulin resistance in prediabetes: evidence of a cross talk between bone and glucose metabolism","volume":"38","author":"Daniele","year":"2015","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.bone.2017.03.053_bb0115","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1210\/jc.2011-2186","article-title":"Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus","volume":"97","author":"Garcia-Martin","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1\u20133","key":"10.1016\/j.bone.2017.03.053_bb0120","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.regpep.2009.06.010","article-title":"Exendin-4 exerts osteogenic actions in insulin-resistant and type 2 diabetic states","volume":"159","author":"Nuche-Berenguer","year":"2010","journal-title":"Regul. Pept."},{"issue":"1","key":"10.1016\/j.bone.2017.03.053_bb0125","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1210\/jc.2011-2152","article-title":"Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults","volume":"97","author":"Amrein","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.bone.2017.03.053_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019595","article-title":"The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells","volume":"6","author":"Zhu","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bone.2017.03.053_bb0135","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.2337\/dc12-1691","article-title":"Atherosclerotic disease in type 2 diabetes is associated with an increase in sclerostin levels","volume":"36","author":"Morales-Santana","year":"2013","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.bone.2017.03.053_bb0140","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ando.2010.02.001","article-title":"The lipid triad, or how to reduce residual cardiovascular risk?","volume":"71","author":"Girard-Mauduit","year":"2010","journal-title":"Ann. Endocrinol."},{"key":"10.1016\/j.bone.2017.03.053_bb0145","article-title":"Sclerostin does not play a major role in the pathogenesis of skeletal complications in type 2 diabetes mellitus","author":"Pereira","year":"2016","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2017.03.053_bb0150","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bone.2015.05.016","article-title":"Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice","volume":"78","author":"Harvey","year":"2015","journal-title":"Bone"},{"issue":"11","key":"10.1016\/j.bone.2017.03.053_bb0155","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1002\/jbmr.1759","article-title":"Type 2 diabetes and bone","volume":"27","author":"Leslie","year":"2012","journal-title":"J. Bone Miner. Res."},{"issue":"10","key":"10.1016\/j.bone.2017.03.053_bb0160","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1210\/jc.2013-2143","article-title":"Elevated sclerostin levels are associated with vertebral fractures in patients with type 2 diabetes mellitus","volume":"98","author":"Yamamoto","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.bone.2017.03.053_bb0165","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1210\/jc.2012-1901","article-title":"Sclerostin levels associated with inhibition of the Wnt\/beta-catenin signaling and reduced bone turnover in type 2 diabetes mellitus","volume":"97","author":"Gaudio","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.bone.2017.03.053_bb0170","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1530\/EJE-14-0106","article-title":"Gender differences in sclerostin and clinical characteristics in type 1 diabetes mellitus","volume":"171","author":"Catalano","year":"2014","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"10.1016\/j.bone.2017.03.053_bb0175","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.tem.2009.12.002","article-title":"Does osteocytic SOST suppression mediate PTH bone anabolism?","volume":"21","author":"Kramer","year":"2010","journal-title":"Trends Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bone.2017.03.053_bb0180","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S8756-3282(03)00169-8","article-title":"Effects of combined treatment of insulin and human parathyroid hormone(1-34) on cancellous bone mass and structure in streptozotocin-induced diabetic rats","volume":"33","author":"Suzuki","year":"2003","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.bone.2017.03.053_bb0185","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/jbmr.1560","article-title":"Weight loss in obese older adults increases serum sclerostin and impairs hip geometry but both are prevented by exercise training","volume":"27","author":"Armamento-Villareal","year":"2012","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.bone.2017.03.053_bb0190","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.bone.2012.06.006","article-title":"Sclerostin levels and bone turnover markers in adolescents with anorexia nervosa and healthy adolescent girls","volume":"51","author":"Faje","year":"2012","journal-title":"Bone"},{"issue":"9","key":"10.1016\/j.bone.2017.03.053_bb0195","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1210\/jc.2015-2002","article-title":"Spinal bone texture assessed by trabecular bone score in adolescent girls with anorexia nervosa","volume":"100","author":"Donaldson","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.bone.2017.03.053_bb0200","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/ajmg.a.20245","article-title":"Congenital generalized lipodystrophy, mental retardation, deafness, short stature, and slender bones: a newly recognized syndrome?","volume":"121A","author":"Rajab","year":"2003","journal-title":"Am. J. Med. Genet. A"},{"issue":"1","key":"10.1016\/j.bone.2017.03.053_bb0205","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00198-015-3222-y","article-title":"Trabecular bone score in type 1 diabetes\u2014a cross-sectional study","volume":"27","author":"Neumann","year":"2016","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2017.03.053_bb0210","doi-asserted-by":"crossref","first-page":"197","DOI":"10.22203\/eCM.v024a14","article-title":"Skeletal muscle secreted factors prevent glucocorticoid-induced osteocyte apoptosis through activation of beta-catenin","volume":"24","author":"Jahn","year":"2012","journal-title":"Eur. Cell. Mater."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328217301217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328217301217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T17:02:19Z","timestamp":1750179739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328217301217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":42,"alternative-id":["S8756328217301217"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2017.03.053","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Normal bone density and trabecular bone score, but high serum sclerostin in congenital generalized lipodystrophy","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2017.03.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}